Canadian extraction specialist Neptune, which has transitioned from marine-based oils for the nutrition market to focus on cannabis opportunities, says its budding Forest Remedies line could expand to more than 100 hemp-derived cosmetic, dietary supplement and home-care products under a recently announced collaboration with International Flavors & Fragrances.
Neptune Wellness Solutions Inc. will begin introducing cannabidiol (CBD)-infused and other hemp-derived personal-care products in the US in the first half of 2020, leveraging International Flavors & Fragrances, Inc. expertise and promotional support from American Media LLC.
New topical, aromatherapeutic products will roll out first under the Forest Remedies brand, according to the company’s 11 November release.
Curve Biosciences has developed a "Whole-Body Intelligence" platform using cfDNA from blood to monitor chronic diseases, starting with the liver. Focused on liver cirrhosis and MASH, the company aims to aid in treatment decisions and plans to expand into monitoring other organs.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
L’Oréal and Galderma have signed a memorandum of understanding to collaborate on complementary research projects to discover ‘new avenues and accelerate innovation’ in the field of dermatology. L’Oreal has arranged to purchase a 10% stake in its partner.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
